FDA Inspection 1081928 — Society Hill Reproductive Medicine
The FDA completed an inspection of Society Hill Reproductive Medicine on Feb 7, 2019 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 7, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Philadelphia, PA (United States)